BackLifeMD Overview
LifeMD Inc

LifeMD Target Price

Analysts' average 12-month price target for LifeMD is $7.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.91

Average Target Price

$7.50157.7% upside

6 analysts in the last 4 months

High: $10 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-18H.C. WainwrightYi Chen$9209.3% upsideOpen
2026-08-07KeyBancScott Schoenhaus$571.8% upsideOpen
2026-08-06Lake Street$571.8% upsideOpen
2026-08-06Mizuho Securities$7140.5% upsideOpen
2026-08-06BTIG$9209.3% upsideOpen
2026-05-27H.C. WainwrightYi Chen$10243.6% upsideOpen
2026-03-12Loop Capital MarketsIlya Zubkov$10243.6% upsideOpen
2025-11-24Loop Capital MarketsIlya Zubkov$8174.9% upsideOpen
2025-11-19Mizuho SecuritiesSteven Valiquette$6106.2% upsideOpen
2025-11-19KeyBancScott Schoenhaus$8174.9% upsideOpen
2025-11-18BTIG$10243.6% upsideOpen
2025-07-10Lake StreetBrooks O'Neil$18518.6% upsideOpen
2025-03-12H.C. WainwrightYi Chen$14381.1% upsideOpen
2025-01-08KeyBancScott Schoenhaus$7140.5% upsideOpen
2024-12-10Lake StreetBrooks O'Neil$12312.4% upsideOpen
2024-10-14BTIGKyle Bauser$12312.4% upsideOpen
2024-06-04KeyBancSteve Dechert$12312.4% upsideOpen
2024-04-23BTIGDavid Larsen$14381.1% upsideOpen

LifeMD (LFMD) FAQ

LifeMD (LFMD) currently reports a target price of $7.5. Use the charts on this page to explore LifeMD's target price history and peer comparisons.

Analysts' average 12-month price target for LifeMD is $7.5, about 157.7% upside from the current share price of $2.91. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $7.5, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LifeMD, and consider following LFMD for alerts when major investors trade the stock.

LifeMD is classified in the Healthcare sector. On target price, it currently shows $7.5. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LFMD with unrelated industries.